Total Payments
$2,755
2024 Payments
$512.98
Companies
17
Transactions
91
Medicare Patients
10,272
Medicare Billing
$3.1M
Payment Breakdown by Category
Food & Beverage$2,755 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,755 | 91 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $576.36 | 16 | $0 (2022) |
| Organogenesis Inc. | $518.93 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $387.73 | 21 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $261.43 | 9 | $0 (2024) |
| Lilly USA, LLC | $229.70 | 9 | $0 (2024) |
| Amgen Inc. | $216.67 | 3 | $0 (2020) |
| GENZYME CORPORATION | $158.72 | 4 | $0 (2021) |
| Genentech USA, Inc. | $118.42 | 1 | $0 (2017) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $83.67 | 4 | $0 (2024) |
| UCB, Inc. | $55.20 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $512.98 | 32 | Novartis Pharmaceuticals Corporation ($164.07) |
| 2023 | $423.86 | 4 | Organogenesis Inc. ($376.45) |
| 2022 | $206.83 | 5 | ABBVIE INC. ($141.62) |
| 2021 | $446.95 | 16 | AbbVie Inc. ($304.71) |
| 2020 | $200.26 | 12 | AbbVie Inc. ($48.72) |
| 2019 | $18.06 | 1 | AbbVie, Inc. ($18.06) |
| 2018 | $319.50 | 12 | Lilly USA, LLC ($105.13) |
| 2017 | $626.92 | 9 | Amgen Inc. ($200.09) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: WOUND CARE | ||||||
| 12/13/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: WOUND CARE | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.79 | General |
| 11/19/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.85 | General |
| 11/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: WOUND CARE | ||||||
| 10/29/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.85 | General |
| 10/09/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: WOUND CARE | ||||||
| 10/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/20/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: WOUND CARE | ||||||
| 09/05/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: WOUND CARE | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Dermatology | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: Dermatology | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Dermatology | ||||||
| 07/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: Dermatology | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Immunology | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.44 | General |
| 05/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Dermatology | ||||||
| 05/07/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $3.83 | General |
| 04/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 2,576 | 4,006 | $4.9M | $958,229 |
| 2022 | 41 | 2,733 | 3,791 | $5.4M | $790,325 |
| 2021 | 42 | 2,589 | 3,851 | $3.3M | $705,223 |
| 2020 | 39 | 2,374 | 3,558 | $2.1M | $609,912 |
Total Patients
10,272
Total Services
15,206
Medicare Billing
$3.1M
Procedure Codes
167
All Medicare Procedures & Services
167 procedure records from CMS Medicare Utilization — Page 7 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 13121 | Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | Office | 2020 | 24 | 24 | $21,184 | $4,562 | 21.5% |
| 12042 | Repair of wound (2.6 to 7.5 centimeters) of neck, hands, feet, and/or genitals | Office | 2020 | 32 | 34 | $20,616 | $4,312 | 20.9% |
| 12051 | Repair of wound (2.5 centimeters or less) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2020 | 35 | 36 | $20,747 | $3,940 | 19.0% |
| 17272 | Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals | Office | 2020 | 29 | 35 | $13,175 | $3,060 | 23.2% |
| 11642 | Removal of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips | Office | 2020 | 23 | 24 | $16,189 | $2,680 | 16.6% |
| 12053 | Repair of wound (5.1 to 7.5 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2020 | 19 | 19 | $13,079 | $2,634 | 20.1% |
| 17282 | Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | Office | 2020 | 19 | 20 | $8,446 | $2,234 | 26.5% |
| 69100 | Biopsy of ear | Office | 2020 | 45 | 54 | $12,203 | $2,071 | 17.0% |
| 17000 | Destruction of skin growth | Office | 2020 | 47 | 54 | $7,741 | $1,879 | 24.3% |
| 11622 | Removal of malignant growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals | Office | 2020 | 15 | 16 | $8,957 | $1,555 | 17.4% |
| 11603 | Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs | Office | 2020 | 11 | 11 | $6,231 | $1,308 | 21.0% |
| 12041 | Repair of wound (2.5 centimeters or less) of neck, hands, feet, and/or genitals | Office | 2020 | 11 | 11 | $5,569 | $1,184 | 21.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 23 | 26 | $2,375 | $903.94 | 38.1% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 17 | 17 | $3,063 | $743.99 | 24.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 26 | 106 | $2,044 | $433.56 | 21.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 13 | 13 | $483.70 | $143.80 | 29.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 14 | 64 | $237.14 | $73.00 | 30.8% |
About Dr. Christopher Wolfe, DO
Dr. Christopher Wolfe, DO is a Dermatology healthcare provider based in Panama City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1417073503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Wolfe, DO has received a total of $2,755 in payments from pharmaceutical and medical device companies, with $512.98 received in 2024. These payments were reported across 91 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,755).
As a Medicare-enrolled provider, Wolfe has provided services to 10,272 Medicare beneficiaries, totaling 15,206 services with total Medicare billing of $3.1M. Data is available for 4 years (2020–2023), covering 167 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, MOHS-Micrographic Surgery
- Location Panama City, FL
- Active Since 03/21/2007
- Last Updated 06/09/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1417073503
Products in Payments
- Puraply (Medical Supply) $376.45
- VRAYLAR (Drug) $231.84
- Enbrel (Biological) $216.67
- DUPIXENT (Biological) $166.03
- COSENTYX (Biological) $163.87
- DUPIXENT DUPILUMAB INJECTION (Biological) $127.99
- COSENTYX (Drug) $119.51
- UBRELVY (Drug) $119.39
- TALTZ (Drug) $116.14
- SKYRIZI (Biological) $99.81
- DISEASE STATE (Drug) $97.47
- Humira (Biological) $81.31
- CYGNUS DUAL (Medical Supply) $78.44
- HUMIRA (Biological) $65.80
- ILUMYA (Biological) $43.27
- Bimzelx (Biological) $38.08
- TREMFYA (Drug) $29.72
- LIBTAYO (Biological) $28.66
- AMELUZ (Drug) $27.94
- EBGLYSS (Drug) $23.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.